NCT07463079Completed
Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema
Source: ClinicalTrials.gov · Last updated 31 Jul 2026
Brief summary (registry, in English)
To investigate the safety and efficacy of the moisturizing lotion in improving eczema symptoms among individuals with atopic eczema in Malaysia. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4. The main questions this study aims to answer are: 1. To investigate the safety of the moisturizing lotion for individuals with atopic eczema in Malaysia. 2. To determine the efficacy of the moisturizing lotion in improving eczema lesions among individuals with atopic eczema in Malaysia. 3. To assess the participants' satisfaction after using the moisturizing lotion.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 4 Mar 2026
- Start date
- 1 Feb 2026
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- USMARI Research & Innovation Centre
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07463079
What you commit to
- Study type: Interventional
- Participants enrolled: 15
- From 1 Feb 2026 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently undergoing or requiring active drug treatment for atopic dermatitis or eczema
- Use of any medication (topical or systemic) that could interfere with the study aim (e.g. corticosteroids, calcineurin inhibitors, methotrexate) 3 months prior to the start of the study treatment and throughout the study
Other illness
- History of allergies or adverse reactions to moisturizers or components of the specific products being tested
- History of chronic allergies
- Participants with documented autoimmune diseases.
- Presence of dermatological or systemic disorder other than eczema that could interfere with study outcomes
Other
- Pregnant, breastfeeding women, or those planning pregnancy during the study period
- Current participation in another interventional clinical study
Who the study is looking for
- Healthy Malaysian women and men
- Age above 18 years old
- Clinically diagnosed with eczema with mild to moderate severity on any parts of the body as evaluated by Eczema Area and Severity Index (EASI) (score 10-20).
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| USMARI Research & Innovation Centre Coordinator of this site? Confirm its status | Petaling Jaya | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.